Torthaí cuardaigh - Isabelle Guillemin

  • 1 - 19 toradh as 19 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Correlation between Quinolone Susceptibility Patterns and Sequences in the A and B Subunits of DNA Gyrase in Mycobacteria

    Correlation between Quinolone Susceptibility Patterns and Sequences in the A and B Subunits of DNA Gyrase in Mycobacteria de réir Isabelle Guillemin, Vincent Jarlier, Emmanuelle Cambau

    Foilsithe / Cruthaithe 1998
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial

    Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial de réir Muriel Viala-Danten, Susan Martin, Isabelle Guillemin, Ron D. Hays

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    A Shared Vesicular Carrier Allows Synaptic Corelease of GABA and Glycine

    A Shared Vesicular Carrier Allows Synaptic Corelease of GABA and Glycine de réir Sonja M. Wojcik, Shutaro Katsurabayashi, Isabelle Guillemin, Eckhard Friauf, Christian Rosenmund, Nils Brose, JeongSeop Rhee

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Oligomerization of KCC2 Correlates with Development of Inhibitory Neurotransmission

    Oligomerization of KCC2 Correlates with Development of Inhibitory Neurotransmission de réir Peter Blaesse, Isabelle Guillemin, Jens Schindler, Michaela Schweizer, Eric Delpire, Leonard Khiroug, Eckhard Friauf, Hans Gerd Nothwang

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Reappraisal of Vipera aspis Venom Neurotoxicity

    Reappraisal of Vipera aspis Venom Neurotoxicity de réir Elisabeth Ferquel, Luc de Haro, Virginie Jan, Isabelle Guillemin, Sabine Jourdain, Alexandre Teynié, Jacques d’Alayer, Valérie Choumet

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Development of Sinonasal Outcome Test (SNOT‐22) Domains in Chronic Rhinosinusitis With Nasal Polyps

    Development of Sinonasal Outcome Test (SNOT‐22) Domains in Chronic Rhinosinusitis With Nasal Polyps de réir Asif Khan, Matthew Reaney, Isabelle Guillemin, Lauren Nelson, Shanshan Qin, Siddhesh Kamat, Leda Mannent, Nikhil Amin, Diane Whalley, Claire Hopkins

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    KCC2 regulates actin dynamics in dendritic spines via interaction with β-PIX

    KCC2 regulates actin dynamics in dendritic spines via interaction with β-PIX de réir Olaya Llano, Smirnov Sv, Shetal Soni, Andrey Golubtsov, Isabelle Guillemin, Pirta Hotulainen, Igor Medina, Hans Gerd Nothwang, Claudio Rivera, Anastasia Ludwig

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice—development and results from a pilot study

    SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice—development and results from a pilot study de réir Andrea Giustina, John S. Bevan, Marcello D. Bronstein, Felipe F. Casanueva, Philippe Chanson, Stephan Petersenn, Xuan-Mai Truong Thanh, Caroline Sert, Aude Houchard, Isabelle Guillemin, Шломо Мелмед

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies

    Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies de réir Stella E. Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda Mannent, Yongtao Li, Shahid Siddiqui, Chien‐Chia Chuang, Siddhesh Kamat, Asif Khan

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis

    Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis de réir Eric L. Simpson, Laurent Eckert, Abhijit Gadkari, Usha G. Mallya, Min Yang, Lauren Nelson, T. Michelle Brown, Matt Reaney, Puneet Mahajan, Isabelle Guillemin, Mark Boguniewicz, David M. Pariser

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)

    Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT) de réir David M. Pariser, Eric L. Simpson, Abhijit Gadkari, Thomas Bieber, David J. Margolis, T. Michelle Brown, Lauren Nelson, Puneet Mahajan, Matthew Reaney, Isabelle Guillemin, Usha G. Mallya, Laurent Eckert

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Sagit©: A Novel Clinician-Reported Outcome for Managing Acromegaly in Clinical Practice

    Sagit©: A Novel Clinician-Reported Outcome for Managing Acromegaly in Clinical Practice de réir Andrea Giustina, John S. Bevan, Marcello D. Bronstein, Felipe F. Casanueva, Philippe Chanson, Stephan Petersenn, Thanh X.M. Truong, Christine Massien, Carla Dias-Barbosa, Isabelle Guillemin, B Arnould, Шломо Мелмед

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Preliminary Testing of the Sagit Tool: A Tool to Help Endocrinologists in Their Management of Patients with Acromegaly in Clinical Practice

    Preliminary Testing of the Sagit Tool: A Tool to Help Endocrinologists in Their Management of Patients with Acromegaly in Clinical Practice de réir Andrea Giustina, John S. Bevan, Marcello D. Bronstein, Felipe F. Casanueva, P. Chanson, Stephan Petersenn, Xuan Mai Truong Thanh, Christine Massien, Carla Dias Barbosa, Isabelle Guillemin, B Arnould, Шломо Мелмед

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Atopic dermatitis in the pediatric population

    Atopic dermatitis in the pediatric population de réir Jonathan I. Silverberg, S. Barbarot, Abhijit Gadkari, Eric L. Simpson, Stephan Weidinger, Paola Mina‐Osorio, Ana B. Rossi, Lysel Brignoli, Grèce Saba, Isabelle Guillemin, Miriam C. Fenton, S. Auziere, Laurent Eckert

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Measurement of health‐related quality of life with glaucoma: validation of the Glau‐QoL<sup>©</sup> 36‐item questionnaire

    Measurement of health‐related quality of life with glaucoma: validation of the Glau‐QoL<sup>©</sup> 36‐item questionnaire de réir A Béchetoille, B Arnould, Alain Bron, Christophe Baudouin, Jean‐Paul Renard, E Sellem, Y Brouquet, Philippe Denis, Jean‐Philippe Nordmann, Marie‐Claude Rigeade, Ana Bassols, K Benmedjahed, Isabelle Guillemin, Jean‐François Rouland

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Burden of atopic dermatitis in paediatric patients: an international cross-sectional study

    Burden of atopic dermatitis in paediatric patients: an international cross-sectional study de réir Stephan Weidinger, Eric L. Simpson, Jonathan I. Silverberg, S. Barbarot, Laurent Eckert, Paola Mina‐Osorio, Ana B. Rossi, Lysel Brignoli, Tarek Mnif, Isabelle Guillemin, Miriam C. Fenton, Dimittri Delevry, Chien‐Chia Chuang, Marine Pellan, Abhijit Gadkari

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS

    Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 stud... de réir Jonathan I. Silverberg, Gil Yosipovitch, Eric L. Simpson, Brian Kim, Jashin J. Wu, Laurent Eckert, Isabelle Guillemin, Zhen Chen, Marius Ardeleanu, Ashish Bansal, Mandeep Kaur, Ana B. Rossi, Neil M.H. Graham, Naimish Patel, Abhijit Gadkari

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    The Family Impact of Atopic Dermatitis in the Pediatric Population: Results from an International Cross-sectional Study

    The Family Impact of Atopic Dermatitis in the Pediatric Population: Results from an International Cross-sectional Study de réir S. Barbarot, Jonathan I. Silverberg, Abhijit Gadkari, Eric L. Simpson, Stephan Weidinger, Paola Mina‐Osorio, Ana B. Rossi, Lysel Brignoli, Tarek Mnif, Isabelle Guillemin, Miriam C. Fenton, Marine Pellan, Puneet Mahajan, Dimittri Delevry, Ashish Bansal, Laurent Eckert

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to &lt; 12 years with uncontrolled severe atopic dermatitis: results from an open‐label phase IIa study and subsequent phase III open‐label extension study

    Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to &lt; 12 years with uncontrolled severe atopic dermatitis: results from an open‐label phase IIa s... de réir Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield, Peter D. Arkwright, Xun Sun, Z. Chen, Bolanle Akinlade, Susan Boklage, Isabelle Guillemin, Matthew P. Kosloski, Mohamed Kamal, John T. O’Malley, Naimish Patel, Neil M.H. Graham, Ashish Bansal

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: